enVVeno Medical (NVNO) Net Cash Flow (2017 - 2026)

enVVeno Medical's Net Cash Flow history runs 10 years deep, the most recent figure standing at -$468000.0 for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 139.56% year-over-year to -$468000.0 in Q1 2026; TTM through Mar 2026 was -$581000.0, a 193.26% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 170.26% from the prior year.
• Net Cash Flow fell to -$468000.0 in Q1 2026 per NVNO's latest filing, from $1.5 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $15.5 million in Q3 2024 and bottomed at -$42.3 million in Q2 2022.
• The 5-year median for Net Cash Flow is -$741000.0 (2025), against an average of -$4.6 million.
• Across the five-year window, Net Cash Flow plunged 1733.55% in 2023 and soared 6596.12% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $1.7 million in 2022, then plunged by 1733.55% to -$27.1 million in 2023, then soared by 40.4% to -$16.2 million in 2024, then jumped by 109.41% to $1.5 million in 2025, then slumped by 130.77% to -$468000.0 in 2026.
• Per Business Quant, the three latest NVNO Net Cash Flow figures stand at -$468000.0 (Q1 2026), $1.5 million (Q4 2025), and -$741000.0 (Q3 2025).